Click to go to homepage
You are not currently logged in

 Basket Items: 0    Total: 0.00 


UK government seeking price cuts of up to 20% for some drugs


The UK government is consulting on proposals to cut prices of some branded drugs by up to 20%, which could also affect negotiations on a new voluntary agreement covering other branded drugs, according to a Thursday announcement.

The Department of Health said it was consulting on a new statutory pricing scheme for branded drugs not covered by the voluntary Pharmaceutical Price Regulation Scheme (PPRS), which caps pharma profits based partly on local R&D spend and is being renegotiated with the industry's trade body.

The proposals, which according to the Association of the British Pharmaceutical Industry (ABPI) estimates will apply to around 10% of UK medicines, do not cover generics or unprescribed branded products available over the counter.

According to the DoH, the suggested price cuts for branded medicines covered by the statutory scheme used for non-PPRS members will be either 10%, 15%, or 20%.

The new scheme is due to come into force on January 1, the same time as the new PPRS and the proposed value-based pricing scheme for new drugs.


» Send this news item to a friend or colleague

« Back to list


Quick Links

Get a quote today!


Wilmington plc e-shot  |  Developed by